These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34152965)

  • 21. Serotype Distribution, Antimicrobial Susceptibility, and Multilocus Sequencing Type (MLST) of
    Li XX; Xiao SZ; Gu FF; Zhao SY; Xie Q; Sheng ZK; Ni YX; Qu JM; Han LZ
    Front Cell Infect Microbiol; 2019; 9():407. PubMed ID: 31828048
    [No Abstract]   [Full Text] [Related]  

  • 22. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotype-Switch Variant of Multidrug-Resistant Streptococcus pneumoniae Sequence Type 271.
    Scherer EM; Beall B; Metcalf B
    Emerg Infect Dis; 2021 Jun; 27(6):1689-1692. PubMed ID: 33915076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of Latin American invasive Streptococcus pneumoniae serotype 19A isolates.
    Moreno J; Duarte C; Cassiolato AP; Chacón GC; Alarcon P; Sánchez J; Martín YNS; Valenzuela C; Castillo W; Gabarrot GG;
    Vaccine; 2020 Apr; 38(19):3524-3530. PubMed ID: 32204942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan.
    Yanagihara K; Kosai K; Mikamo H; Mukae H; Takesue Y; Abe M; Taniguchi K; Petigara T; Kaku M
    Int J Infect Dis; 2021 Jan; 102():260-268. PubMed ID: 33065297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction.
    Echániz-Aviles G; Guerreiro SI; Silva-Costa C; Mendes CI; Carriço JA; Carnalla-Barajas MN; Soto-Noguerón A; Velazquez-Meza ME; Melo-Cristino J; Luévanos-Velazquez A; Martínez-Medina L; Vázquez-Larios MDR; Ramirez M
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30404945
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults.
    Nakanishi N; Yonezawa T; Tanaka S; Shirouzu Y; Naito Y; Ozaki A; Hama N; Ijichi A; Iwamoto T; Nomoto R
    J Infect Public Health; 2019; 12(6):867-872. PubMed ID: 31204116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.
    Tyrrell GJ; Lovgren M; Chui N; Minion J; Garg S; Kellner JD; Marrie TJ
    Vaccine; 2009 Jun; 27(27):3553-60. PubMed ID: 19464534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute otitis media caused by Streptococcus pneumoniae serotype 19A ST320 clone: epidemiological and clinical characteristics.
    Chi H; Chiu NC; Huang FY; Hsu CH; Lee KS; Huang LM; Hsieh YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):337-343. PubMed ID: 28087317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.
    Golden AR; Adam HJ; Zhanel GG;
    Vaccine; 2016 May; 34(23):2527-30. PubMed ID: 27085174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.
    Gladstone RA; Siira L; Brynildsrud OB; Vestrheim DF; Turner P; Clarke SC; Srifuengfung S; Ford R; Lehmann D; Egorova E; Voropaeva E; Haraldsson G; Kristinsson KG; McGee L; Breiman RF; Bentley SD; Sheppard CL; Fry NK; Corander J; Toropainen M; Steens A;
    Vaccine; 2022 Feb; 40(7):1054-1060. PubMed ID: 34996643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
    J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptococcus pneumoniae infection: a Canadian perspective.
    Deng X; Church D; Vanderkooi OG; Low DE; Pillai DR
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):781-91. PubMed ID: 23977934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.
    Vanderkooi OG; Church DL; MacDonald J; Zucol F; Kellner JD
    PLoS One; 2011; 6(12):e28547. PubMed ID: 22216100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
    Golden AR; Adam HJ; Karlowsky JA; Baxter M; Nichol KA; Martin I; Demczuk W; Van Caeseele P; Gubbay JB; Lefebvre B; Levett PN; Zahariadis G; Haldane D; Gad R; German G; Gilmour MW; Mulvey MR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2018 Jul; 73(suppl_7):vii20-vii31. PubMed ID: 29982573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
    Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
    J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of
    Camacho Moreno G; Imbachi LF; Leal AL; Moreno VM; Patiño JA; Gutiérrez IF; Beltrán S; Álvarez-Olmos MI; Mariño C; Barrero R; Espinosa F; Ramos N; Castellar LP; Sánchez N; Montañez A
    Hum Vaccin Immunother; 2020 Sep; 16(9):2300-2306. PubMed ID: 32078398
    [No Abstract]   [Full Text] [Related]  

  • 40. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Goettler D; Streng A; Kemmling D; Schoen C; von Kries R; Rose MA; van der Linden M; Liese JG
    Vaccine; 2020 Jan; 38(3):570-577. PubMed ID: 31735502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.